Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;53(11):1418-1427.
doi: 10.1038/s41409-018-0118-4. Epub 2018 Feb 14.

Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients

Affiliations

Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients

Daniel R Richardson et al. Bone Marrow Transplant. 2018 Nov.

Abstract

Hematopoietic cell transplantation (HCT) is an intensive treatment resulting in disease control however subsequent psychosocial distress is common. Screening for psychosocial risk factors that contribute to morbidity is underutilized; moreover, the value in screening is uncertain. We performed a retrospective study of 395 HCT patients who were screened for psychosocial risk using the Transplant Evaluation Rating Scale (TERS). Patients were classified by psychosocial risk as no-risk (TERS = 26.5, 52%) vs. at-risk (TERS > 26.5, 48%), with at-risk patients stratified by cumulative deficits into mild risk (TERS = 27-35.5, 39%) and moderate risk (TERS > 35.5, 9%). At-risk patients were more likely to be readmitted within 90 days (mild risk HR = 1.62, p = 0.02; moderate risk HR = 2.50, p = 0.002). Prior psychiatric history (HR = 1.81, p = 0.002) and poor coping skills (HR = 1.64, p = 0.04) also influenced readmission. At-risk patients were more likely to be readmitted for infection (no-risk = 12% vs. at-risk = 25%, p = 0.002). Pre-HCT screening with the TERS did not predict survival or length of stay although at-risk patients are at a heighted risk of readmission. Implementing strategies to reduce readmission in higher risk patients is warranted.

PubMed Disclaimer

Conflict of interest statement

Author Disclosure: The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Cumulative incidence of hospital readmission with death as a competing risk illustrating the association between psychosocial risk as measured by the TERS and readmission in (a) all patients, (b) patients receiving an autologous HCT, and (c) patients receiving an allogeneic HCT. In analyzing all patients together, there is significant separation between the three groups with respect to incidence of readmission. For patients receiving an autologous HCT, there is a significant difference between the moderate risk patients and the other two groups. For patients receiving an allogeneic HCT, there is a significant difference between no-risk patients and the other two groups.

References

    1. Hefner J, Kapp M, Drebinger K, Dannenmann A, Einsele H, Grigoleit GU, et al. High prevalence of distress in patients after allogeneic hematopoietic SCT: Fear of progression is associated with a younger age. Bone Marrow Transplantation. 2014;49(4):581–584. doi: 10.1038/bmt.2013.228. - DOI - PubMed
    1. Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psycho-Oncology. 2009;18(2):113–127. doi: 10.1002/pon.1399. - DOI - PMC - PubMed
    1. Kuba K, Esser P, Scherwath A, Schirmer L, Schulz-Kindermann F, Dinkel A, et al. Cancer-and-treatment-specific distress and its impact on posttraumatic stress in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) Psycho-Oncology. 2017;26(8):1164–1171. doi: 10.1002/pon.4295. - DOI - PubMed
    1. Goetzmann L, Klaghofer R, Wagner-Huber R, Halter J, Boehler A, Muellhaupt B, et al. Psychosocial vulnerability predicts psychosocial outcome after an organ transplant: Results of a prospective study with lung, liver, and bone-marrow patients. Journal of Psychosomatic Research. 2007;62(1):93–100. doi: 10.1016/j.jpsychores.2006.07.023. - DOI - PubMed
    1. Illescas-Rico R, Amaya-Ayala F, Jimenez-Lopez JL, Caballero-Mendez ME, Gonzalez-Llaven J. Increased incidence of anxiety and depression during bone marrow transplantation. Archives of Medical Research. 2002;33(2):144–147. doi: 10.1016/s0188-4409(01)00363-0. - DOI - PubMed

Publication types

LinkOut - more resources